<DOC>
	<DOC>NCT01156337</DOC>
	<brief_summary>The study was aimed to verify the effects of Hypertonic saline solution (HSS) and a moderate sodium (Na) restriction plus high furosemide dose in the short term (hospitalization time) and a moderate Na restriction in the long term on readmissions and mortality in patients in III NYHA class.</brief_summary>
	<brief_title>Sodium Management in Acute and Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Decompensated HF due to ischemic or nonischemic cardiomyopathy, &gt;18 years of age, HF according to Framingham criteria NYHA functional class III EF &lt;40%, Serum creatinine &lt;2,5 mg/dL BUN &lt;60 mg/dL, Exclusion criteria: NYHA class &gt; III or &lt; III, Cerebral vascular disease, Dementia, Cancer, Uncompensated diabetes, Severe hepatic disease Patients requiring pacemaker Previous RCT implantation Alcoholic habit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Heart failure III NYHA class</keyword>
	<keyword>Furosemide</keyword>
	<keyword>Sodium</keyword>
	<keyword>water restriction</keyword>
	<keyword>decompensated heart failure</keyword>
	<keyword>Hypertonic saline solution</keyword>
	<keyword>Moderate sodium restriction</keyword>
</DOC>